Let’s be honest there are days we’d rather be lucky than good. This morning while checking our email we came across an email that wasn’t meant for us but certainly caught our attention. It seems that our friends at Medtronic are getting very close to selling their diabetes franchise to a group of private equity firms. According to the documents we obtained this project is code named Icarus and outlines not just how this transaction will take place but what the plans are once the transaction is consummated.
Far as we can tell Medtronic considered . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.